IFP Advisors’s Albany Molecular Research Inc AMRI Stock Holding History

IFP Advisors’s Portfolio AMRI Stock Details AMRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-60	Closed	-$1K	–	4364
2017 Q2	$1K	Hold	60	–	–	﹤0.01%	4032
2017 Q1	$1K	Sell	60 -137	-70%	-$2.24K	﹤0.01%	3934
2016 Q4	$4K	Buy	197 +137	+228%	+$2.33K	﹤0.01%	3465
2016 Q3	$1K	Hold	60	–	–	﹤0.01%	3846
2016 Q2	$1K	Buy	+60	New	+$875	﹤0.01%	3763
2016 Q1	–	Sell	-60	Closed	-$1K	–	4039
2015 Q4	$1K	Buy	+60	New	+$1.14K	﹤0.01%	3646

Other funds holding AMRI

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors's AMRI Position: Q3 2017 in Review

IFP Advisors sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 60 shares — an estimated $1K sold.

IFP Advisors first reported a position in AMRI in Q4 2015 and held it in 6 quarters. The position peaked at $4K in Q4 2016. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

IFP Advisors reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
IFP Advisors sold 60 Albany Molecular Research Inc shares in Q3 2017, an estimated $1K.
IFP Advisors first reported a position in Albany Molecular Research Inc in Q4 2015 and held it in 6 quarters.
IFP Advisors's Albany Molecular Research Inc position peaked at $4K in Q4 2016.
2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on IFP Advisors's 13F filing for Q3 2017, filed 30 Oct 2017.